Accenture Operating Cash Flow increased by 129.4% to $3.82B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 33.8%, from $2.85B to $3.82B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 6.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.40B | $2.44B | $530.87M | $2.16B | $3.06B | $3.79B | $495.40M | $2.33B | $3.29B | $3.41B | $498.55M | $2.10B | $3.14B | $3.39B | $1.02B | $2.85B | $3.68B | $3.91B | $1.66B | $3.82B |
| QoQ Change | — | +1.5% | -78.2% | +306.0% | +42.2% | +23.7% | -86.9% | +370.4% | +41.2% | +3.6% | -85.4% | +321.4% | +49.5% | +7.9% | -69.8% | +179.1% | +29.1% | +6.2% | -57.5% | +129.4% |
| YoY Change | — | — | — | — | +27.6% | +55.6% | -6.7% | +8.1% | +7.3% | -10.0% | +0.6% | -9.8% | -4.5% | -0.6% | +105.1% | +35.8% | +17.3% | +15.5% | +62.8% | +33.8% |